|
EHF expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.71389999997973E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.50760999999555E-05 |
| Normal-vs-Stage2 |
1.4837999999795E-06 |
| Normal-vs-Stage3 |
6.00469999945119E-07 |
| Normal-vs-Stage4 |
8.61750000025197E-07 |
| Stage1-vs-Stage2 |
2.445800E-01 |
| Stage1-vs-Stage3 |
7.418100E-03 |
| Stage1-vs-Stage4 |
6.449700E-02 |
| Stage2-vs-Stage3 |
5.355400E-01 |
| Stage2-vs-Stage4 |
7.823800E-01 |
| Stage3-vs-Stage4 |
5.548200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.19229999998127E-06 |
| Normal-vs-AfricanAmerican |
1.59033999999059E-05 |
| Normal-vs-Asian |
3.59459999998979E-06 |
| Caucasian-vs-AfricanAmerican |
4.331800E-01 |
| Caucasian-vs-Asian |
9.110200E-01 |
| AfricanAmerican-vs-Asian |
7.204000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.14799999995085E-06 |
| Normal-vs-Female |
2.172100E-04 |
| Male-vs-Female |
1.321710E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.96807999999216E-05 |
| Normal-vs-Extreme_Weight |
8.90879999992933E-07 |
| Normal-vs-Obese |
1.64169999999908E-05 |
| Normal-vs-Extreme_Obese |
2.85060000049242E-07 |
| Normal_Weight-vs-Extreme_Weight |
1.740770E-01 |
| Normal_Weight-vs-Obese |
9.294800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.218400E-02 |
| Extreme_Weight-vs-Obese |
1.398980E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.585700E-02 |
| Obese-vs-Extreme_Obese |
7.995800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.85590000000491E-05 |
| Normal-vs-Age(41-60Yrs) |
2.81150000003283E-06 |
| Normal-vs-Age(61-80Yrs) |
2.64890000001294E-06 |
| Normal-vs-Age(81-100Yrs) |
2.82150000030512E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.464200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.515000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.964100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.552000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.416600E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.552100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.69809999973315E-07 |
| Normal-VS-Type2 PRCC |
1.07969999996183E-06 |
| Normal-VS-KIRP CIMP |
4.788200E-04 |
| Normal-VS-Unclassified PRCC |
3.72459999999908E-05 |
| Type1 PRCC-VS-Type2 PRCC |
7.799800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.258360E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.841600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.210300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.446800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.198600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.3647000000061E-06 |
| Normal-vs-N1 |
4.62930000000306E-06 |
| Normal-vs-N2 |
3.439000E-04 |
| N0-vs-N1 |
8.475700E-02 |
| N0-vs-N2 |
1.271620E-01 |
| N1-vs-N2 |
4.862600E-01 |
|
|
